Before pacemakers, stents and other medical devices for the heart are approved for use by the U.S. Food and Drug Administration, the devises must be put through
The Government Accountability Office (GAO) recently released its evaluation on how the FDA has responded to the GAO’s 2009 findings on the shortcomings of the FDA’s premarket
